US Patent Issued to Corcept Therapeutics on July 29 for "Glucocorticoid receptor modulators to treat pancreatic cancer" (British, American Inventors)

ALEXANDRIA, Va., July 30 -- United States Patent no. 12,370,175, issued on July 29, was assigned to Corcept Therapeutics Inc. (Redwood City, Calif.).

"Glucocorticoid receptor modulators to treat pancreatic cancer" was invented by Hazel Hunt (Storrington, Great Britain) and Thaddeus S. Block (Menlo Park, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods and compositions for treating a subject hosting a non-ACTH-secreting pancreatic tumor are disclosed. The methods include administering to the subject a chemotherapeutic agent and a glucocorticoid receptor modulator (GRM), preferably a selective glucocorticoid receptor modulator (SGRM), to reduce the tumor load in the subject. The non-ACTH-secreting...